Evaluation of Z-(R,R)-IQNP for the potential imaging of m2 mAChR rich regions of the brain and heart

Citation
Dw. Mcpherson et al., Evaluation of Z-(R,R)-IQNP for the potential imaging of m2 mAChR rich regions of the brain and heart, LIFE SCI, 66(10), 2000, pp. 885-896
Citations number
43
Categorie Soggetti
Biochemistry & Biophysics
Journal title
LIFE SCIENCES
ISSN journal
00243205 → ACNP
Volume
66
Issue
10
Year of publication
2000
Pages
885 - 896
Database
ISI
SICI code
0024-3205(20000128)66:10<885:EOZFTP>2.0.ZU;2-9
Abstract
Alterations in the function or density of the m2 muscarinic (mAChR) subtype have been postulated to play an important role in various dementias such a s Alzheimer's disease. The ability to image and quantify the m2 mAChR subty pe is of importance for a better understanding of the m2 subtype function i n various dementias. Z-(R)-1-Azabicyclo[2.2.2]oct-3-y (R)-alpha-hydroxy-alp ha-(1-iodo-1-propen-3 -yl)-alpha-phenylacetate (Z-(R,R)-IQNP) has demonstra ted significant uptake in cerebral regions that contain a high concentratio n of m2 mAChR subtype in addition to heart tissue. The present study was un dertaken to determine if the uptake of Z-(R,R)-IQNP in these regions is a r eceptor mediated process and to identify the radiospecies responsible for b inding at the receptor site. A blocking study demonstrated cerebral and. ca rdiac levels of activity were significantly reduced by pretreatment (2-3 mg /kg) of (R)-3-quinuclidinyl benzilate, dexetimide and scopolamine, establis hed muscarinic antagonists. A direct comparison of the cerebral and cardiac uptake of [I-125]-Z-(R,R)-IQNP and [I-131]-E-(R,R)-IQNP (high uptake in m1 , m4 rich mAChR cerebral regions) demonstrated Z-(R,R)-IQNP localized to a higher degree in cerebral and cardiac regions containing a high concentrati on of the m2 mAChR subtype as directly compared to E-(R,R)-IQNP. In additio n, a study utilizing [I-123]-Z(R,R)-IQNP, [I-131]-iododexetimide and [I-125 ]-R-3-quinuclidinyl S-4-iodobenzilate, Z-(R,R)-IQNP demonstrated significan tly higher uptake and longer residence time in those regions which contain a high concentration of the m2 receptor subtype. Folch extraction of global brain and heart tissue at various times post injection of [I-125]-Z-(R,R)- IQNP demonstrated that approximately 80% of the activity was extracted in t he lipid soluble fraction and identified as the parent ligand by TLC and HP LC analysis. These results demonstrate Z-(R,R)-IQNP has significant uptake, long residence time and high stability in cerebral and cardiac tissues con taining high levels of the m2 mAChR subtype. These combined results strongl y suggest that Z-(R,R)-IQNP is an attractive ligand for the in vivo imaging and evaluation of m2 rich cerebral and cardiac regions by SPECT.